Table 1. Risk factors predisposing to CTEPH.
Clinical conditions predisposing to CTEPH |
Large pulmonary emboli |
Recurrent pulmonary emboli |
Insufficient anticoagulation |
Underlying autoimmune and haematological disorders |
Ventriculo-atrial shunts |
Infected pacemaker leads |
Implantable chambers for intravenous chemotherapy (especially when infected) |
Totally implantable central venous access systems |
Splenectomy |
Cancer and chronic myeloproliferative disorders |
Thyroid replacement therapy |
Biological risk factors predisposing to CTEPH |
Non-O blood group |
Presence of lupus anticoagulant/antiphospholipid antibodies* |
*, interestingly, the classical hereditary thrombotic risk factors, e.g., protein C, protein S and antithrombin deficiencies and mutations of factor V and II are not more frequent in patients with CTEPH, compared with healthy controls and patients with pulmonary arterial hypertension. CTEPH, chronic thromboembolic pulmonary hypertension.